In vitro activity of retapamulin against linezolid and methicillin-resistant Staphylococcus aureus isolates;Actividad in vitro de retapamulina frente a cepas de Staphylococcus aureus resistente a meticilina y a linezolid

Revista Espanola de Quimioterapia

Volumn 24, Issue 3, 2011, Pages 127-130

  Candel, Francisco Javier ^a   Morales, Gracia ^a   Picazo, Juan José ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Cfr gene; Nasal carriers; Pleuromutilin; Topical antibiotic therapy

Indexed keywords

BACITRACIN; FUSIDIC ACID; LINEZOLID; PSEUDOMONIC ACID; RETAPAMULIN;

ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; DRUG ACTIVITY; HUMAN; IN VITRO STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLYMERASE CHAIN REACTION;

ACETAMIDES; ANTI-BACTERIAL AGENTS; BACITRACIN; BACTERIAL PROTEINS; BICYCLO COMPOUNDS, HETEROCYCLIC; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MUPIROCIN; OXAZOLIDINONES; POLYMERASE CHAIN REACTION; STAPHYLOCOCCUS AUREUS;

EID: 80054789182     PISSN: 02143429     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Wertheim, HFL, Melles, DC, Vos, MC et al. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis 2005; 5: 751-762.
2. McConeghy, KW, Mikolich, DJ, LaPlante, KL. Agents for the decolonization of methicillin-resistant Staphylococcus aureus. Pharmacotherapy 2009; 29: 263-280.
3. Patel, JB, Gorwitz, RJ, Jernigan, JA. Antimicrobial resistance: Mupirocin resistance. Clin Infect Dis 2009; 49: 935-941.
4. Mongkolrattanothai, K, Pumfrey, L, Mankin, P et al. Acquisition of high-level mupirocin resistance and its fitness cost among methicillin-resistant Staphylococcus aureus strains with lowlevel mupirocin resistance. J Clin Microbiol 2009; 47: 4158-4160.
5. Yan, K, Madden, L, Choudhry, AE et al. Biochemical characterization of the interactions of the novel pleuromutilin derivative retapamulin with bacterial ribosomes. Antimicrob Agents Chemother 2006; 50: 3875-3881.
6. Champney, WS, Rodgers, WK. Retapamulin inhibition of translation and 50S ribosomal subunit formation in Staphylococcus aureus cells. Antimicrob Agents Chemother 2007; 51: 3385-3387.
7. Morales, G, Picazo, J, Baos, E et al. Resistance to linezolid is mediated by the cfr gene in the first reported outbreak of linezolid-resistant Staphylococcus aureus. Clin Infect Dis 2010; 50: 821-825.
8. Sánchez García M, De la Torre MA, Morales G, Peláez B, et al. Clinical outbreak of linezolid-resistant Staphylococcus aureus in an intensive care unit. JAMA 2010; 303: 2260-2264.
9. Traczewski, MM, Brown, SD. Proposed MIC and disk diffusion microbiological cutoffs and spectrum of activity of retapamulin, a novel topical antimicrobial agent. Antimicrob Agents Chemother 2008; 52: 3863-3867.
10. Kehrenberg, C, Schwarz, S. Distribution of florfenicol resistance genes fexA and cfr among chloramphenicol-resistant Staphylococcus isolates. Antimicrob Agents Chemother 2006; 50: 1156-1163.
11. Long, KS, Poehlsgaard, J, Kehrenberg, C et al. The Cfr rRNA methyltransferase confers resistance to phenicols, lincosamides, oxazolidinones, pleuromutilins, and streptogramin A antibiotics. Antimicrob Agents Chemother 2006; 50: 2500-2505.